Truvada (emtricitabine/tenofovir disoproxil fumarate) is a brand-name oral tablet prescribed for HIV treatment and prevention. This article covers topics such as side effects, dosage, and how Truvada ...

Truvada is a type of drug that helps reduce the risk of HIV infection, which is called pre-exposure prophylaxis (PrEP). It blocks an enzyme that the human immunodeficiency virus (HIV) needs to copy ...

The Food and Drug Administration has approved a second medication designed to prevent people from becoming infected with HIV. Foster City, California-based Gilead Sciences said Thursday that the FDA ...

In a major breakthrough in the fight against new HIV transmissions, a British pharmaceutical company has announced that PrEP injections every two months have proven more effective than a once-daily ...

A long-awaited generic version of Truvada, used for both HIV treatment and PrEP, went on the market Friday, October 2. But the wholesale cost of the new pill from Teva Pharmaceuticals – about $1,455 – ...

Descovy demonstrated continued noninferiority to Truvada for HIV pre-exposure prophylaxis and statistically significant differences over Truvada for pre-specified secondary end points. In the phase 3, ...

Clock’s ticking. After an expected FDA nod for Descovy as the second HIV PrEP drug, Gilead Sciences now has one year to convince its current Truvada takers to switch over before generics hit. The FDA ...

“I’m on the pill,” declares a transgender woman in an up-close shot featured in Gilead Science’s latest drug commercial. “But it’s not birth control,” says a young guy, with a smile, in another scene.

Truvada (emtricitabine/tenofovir disoproxil fumarate) and Descovy (emtricitabine/tenofovir alafenamide) are brand-name oral tablets. They’re both approved to treat and prevent HIV. Only Truvada is ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) today announced 96-week results from the DISCOVER trial, a multi-year global Phase 3 registrational clinical trial evaluating ...